Foundation Medicine (FMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 26,328 | 28,824 | 29,426 | 28,237 | 30,378 |
| Cost of Goods | 18,017 | 17,457 | 15,946 | 11,955 | 11,390 |
| Gross Profit | 8,311 | 11,367 | 13,480 | 16,282 | 18,988 |
| Operating Expenses | 55,015 | 47,529 | 45,850 | 46,439 | 36,863 |
| Operating Income | -46,687 | -35,705 | -31,424 | -29,202 | -17,485 |
| Other Income | 234 | 96 | 142 | 208 | 178 |
| Pre-tax Income | -46,453 | -35,609 | -31,282 | -28,994 | -17,307 |
| Net Income Continuous | -46,453 | -35,609 | -31,282 | -28,994 | -17,307 |
| Net Income | $-46,453 | $-35,609 | $-31,282 | $-28,994 | $-17,307 |
| EPS Basic Total Ops | -1.31 | -1.01 | -0.90 | -0.84 | -0.50 |
| EPS Basic Continuous Ops | -1.31 | -1.02 | -0.90 | -0.84 | -0.50 |
| EPS Diluted Total Ops | -1.31 | -1.01 | -0.90 | -0.84 | -0.50 |
| EPS Diluted Continuous Ops | -1.31 | -1.02 | -0.90 | -0.84 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -1.31 | -1.02 | -0.90 | -0.84 | N/A |
| EBITDA(a) | $-42,221 | $-31,284 | $-27,132 | $-25,035 | $-14,416 |